XML 40 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurement of Assets and Liabilities (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis
The following table summarizes the Company’s financial instruments measured at fair value on a recurring basis in accordance with the authoritative guidance for fair value measurements as of December 31, 2020 (in thousands):
Balance as of
December 31, 2020
Level 1
Assets:
Cash equivalents
Money market funds$126 $126 
Total cash equivalents$126 $126 
The following table summarizes the Company’s financial instruments measured at fair value on a recurring basis in accordance with the authoritative guidance for fair value measurements as of December 31, 2019 (in thousands):
Balance as of
December 31, 2019
Level 1
Assets:
Cash equivalents
Money market funds$126 $126 
Total cash equivalents$126 $126 
Balance as of
December 31, 2020
Level 3
Liabilities:
2025 Notes
Interest make-whole payment$4,898 $4,898 
Total embedded derivatives$4,898 $4,898 
Schedule of Fair Value Valuation Model and Assumptions
The fair value of the interest make-whole payment derivative liability was determined using a Monte Carlo model with the following key assumptions:
May 12, 2020December 31, 2020
Volatility60 %50 %
Stock price$10.62 per share$15.47 per share
Credit spread14.97 %19.25 %
Term4.97 years4.34 years
Dividend yield— %— %
Risk-free rate0.34 %0.30 %
Summary of Changes in Fair Value of Level 3 Liabilities
The following table sets forth a summary of changes in the fair value of Level 3 liabilities for the twelve months ended December 31, 2020 (in thousands):
Balance as of
December 31, 2019
AdditionsConversionsChange in fair valueBalance as of
December 31, 2020
Liabilities:
Interest make-whole payment$— $4,582 $(281)$597 $4,898